CD4 and diffuse large B-cell lymphoma: In our study, low CD4:CD8 ratio was associated with poor OS in PG-DLBCL patients who were newly diagnosed and did not receive rituximab, but in patients receiving rituximab, low CD4:CD8 ratio was not associated with poor OS.